• LogicBio Therapeutics Issues Experimental New Drug Application (IND) for LB-001 for …

    In the first half of 2020, LogicBio plans to launch a Phase 1/2 trial during pediatric MMA patients, with preliminary data planned for the second half of …

    Read More
  • 0 0